ReviewFrontiers in cellular and infection microbiology2026
Dynamic regulatory mechanism of cholesterol 25-hydroxylase-mediated antiviral response in RNA virus infections.
Review in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Due to their high mutation rates and adaptability, RNA viruses pose a persistent threat to public health. Cholesterol-25-hydroxylase (CH25H), an interferon-stimulated gene (ISG), produces 25-hydroxycholesterol (25HC), which plays a pivotal role in host defense against RNA virus infections. However, infection outcomes are determined by the dynamic interplay between viral infection and host immune defense, including cholesterol metabolism mediated by CH25H/25HC axis. This review aims to comprehensively elucidate the mechanisms underlying the interaction between CH25H/25HC and RNA viruses. We summarize recent advances in understanding the antiviral mechanisms of CH25H/25HC against RNA viruses, highlighting the central role of CH25H and its metabolite 25HC in inhibiting viral replication and regulating immune cell function. Furthermore, we discuss how RNA viruses evade host immune surveillance through strategies such as gene mutation, suppression of immune pathways, and interference with CH25H expression or function. Moreover, we emphasize endolysosomal cholesterol homeostasis as a host determinant of RNA virus entry, endosomal escape, trafficking, and replication, and discuss cholesterol-modulating host-directed therapies as complementary strategies to direct-acting antivirals. The findings indicate that dynamic regulation of CH25H and its metabolite 25HC is crucial for maintaining a balanced innate immune response against RNA viruses. This review comprehensively elucidated the dynamic molecular interactions between CH25H and RNA viruses, integrating recent research advances with a focus on molecular regulatory mechanisms. By synthesizing these findings, this review provided a mechanistic framework for understanding host-virus conflicts centered on cholesterol metabolism and proposed potential therapeutic strategies targeting this axis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.